Cargando…
HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer
Human epidermal growth factor receptor type 2 (HER2)-positive breast carcinoma is highly aggressive and mostly metastatic in nature though curable/manageable in part by molecular targeted therapy. Recent evidence suggests a subtype of cells within HER2-positive breast tumors that concomitantly expre...
Autores principales: | Chandran, Vineesh Indira, Eppenberger-Castori, Serenella, Venkatesh, Thejaswini, Vine, Kara Lea, Ranson, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394126/ https://www.ncbi.nlm.nih.gov/pubmed/25897424 |
Ejemplares similares
-
Effect of macrophages on breast cancer cell proliferation, and on expression of hormone receptors, uPAR and HER-2
por: Lindsten, Therése, et al.
Publicado: (2017) -
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99
por: Eppenberger-Castori, Serenella, et al.
Publicado: (2020) -
Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221
por: Falkenberg, Natalie, et al.
Publicado: (2015) -
Integrin is on uPAR to unleash cells
por: LeBrasseur, Nicole
Publicado: (2003) -
uPAR's signaling two step
por: Leslie, Mitch
Publicado: (2007)